Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions - A cross-sectional study in six EU member states

CONCLUSION: Knowledge about TTS seemed to have influenced the public's opinion in Europe resulting in less willingness to be vaccinated with Vaxzevria® and Jcovden®. Willingness for vaccination against COVID-19 with other vaccines and widespread use of vaccines to prevent other diseases also differed and seemed to be determined by the approaches taken by national health authorities when reacting to and communicating about COVID-19 vaccination risks. Further investigation of optimal risk communication strategies is warranted.PMID:38182460 | DOI:10.1016/j.vaccine.2023.12.065

Source: Vaccine - January 5, 2024 Category: Allergy & Immunology Authors: Caroline Buhl Ramune Jacobsen Anna Birna Almarsd óttir Shahab Abtahi Armin Andersen Elena Deligianni Foteini Dermiki-Gkana Christos Kontogiorgis Chara Oikonomou Mirdza Kursite Elita Poplavska Ingrid Hegger Marloes van der Goot Paula Bar ão Sousa Ferreir Source Type: research